Clinical Trials at UMMC

Researchers at UMMC are committed to discovering new and innovative ways to prevent and treat the diseases that affect our daily lives, with the ultimate goal to improve the well-being of our families, friends, communities and future generations. However, we cannot do it alone. Clinical research studies are vital to the advancement of medicine and our vision to create "a healthier Mississippi."

Browse our ongoing clinical trials below, and use the left-hand filters to narrow your search.

To learn more about our clinical trials and how to participate, click here.


Search Filters Clear

Keywords
Study Categories
3 Total Trials for "Allergy/Asthma/Immunology"
2 Total Trials for "Arthritis/Rheumatology"
108 Total Trials for "Cancer"
20 Total Trials for "COVID-19 (Coronavirus)"
1 Total Trial for "Dermatology/Skin Care"
1 Total Trial for "Developmental Disorders"
12 Total Trials for "Digestive Conditions"
3 Total Trials for "Emergency Medicine"
2 Total Trials for "Endocrinology/Diabetes"
2 Total Trials for "Eyes/Vision"
6 Total Trials for "Genetics"
1 Total Trial for "Hearing"
20 Total Trials for "Heart Health"
8 Total Trials for "Infectious Diseases"
7 Total Trials for "Kidney/Renal Conditions"
1 Total Trial for "Liver Diseases"
20 Total Trials for "Lungs/Breathing"
2 Total Trials for "Men's Health"
8 Total Trials for "Neurosciences"
2 Total Trials for "Orthopaedics"
1 Total Trial for "Palliative Care"
47 Total Trials for "Pediatrics"
3 Total Trials for "Preventive Medicine"
2 Total Trials for "Rehabilitation Services"
1 Total Trial for "Sleep Medicine"
9 Total Trials for "Stroke/Traumatic Brain Injury"
10 Total Trials for "Surgery"
1 Total Trial for "Transplant"
1 Total Trial for "Weight Management"
16 Total Trials for "Women's Health"
Study Locations
Jackson Metro
Grenada
Holmes County
Study Status



Study Type

Biological Sex
Age
Study Phase




Other Criteria

Clinical Trials Displaying Items 61 - 80 of 230

March 21, 2022

An Open label study to allow patients continuous use of Hemocare hemodialysis system for home hemodialysis prior to market authorization

Locations: Jackson Medical Mall - UMMC Clinics
March 07, 2022

A Phase 2a Multiple Ascending, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GFB-887, a TRPC5 Channel Inhibitor, in Patients with Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Locations: Jackson Medical Mall - UMMC Clinics, Pavilion - UMMC
March 02, 2022

MK-1242-035: A Pivotal Phase 3 Randomized, Placebo-controlled Vericiguat Outcomes Study in HFrEF (VICTOR)

Locations: Emergency Room (Adult) - UMMC, Grants Ferry - UMMC, Pavilion - UMMC, University Heart - UMMC, University Hospital - UMMC, Wiser Hospital for Women and Infants - UMMC
January 31, 2022

Evaluating the Healing of Diabetic Foot Ulcers with Compounded Anti-Infective Irrigation Therapy

Locations: Pavilion - UMMC
January 24, 2022

A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With Fragile X Syndrome - RECONNECT

Locations: Children's of Mississippi - Outpatient Specialty Clinic at Sanderson Tower (Level 1), Children's of Mississippi - Outpatient Specialty Clinic at Sanderson Tower (Level B), University Hospital - UMMC
January 24, 2022

Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes (BRAVO study – Broad-spectrum Rapid Antidote: Varespladib Oral for snakebite)

Locations: Children’s of Mississippi Hospital - Blair E. Batson Tower, Emergency Room (Adult) - UMMC, Emergency Room (Children) - UMMC, University Hospital - UMMC
January 14, 2022

A multicenter, randomized, double-blind, parallel-group, placebo-controlled study to evaluate the efficacy and safety of finerenone on morbidity and mortality in participants with heart failure (NYHA II-IV) and left ventricular ejection fraction ≥ 40% (LVEF ≥ 40%)

Locations: Emergency Room (Adult) - UMMC, Lakeland Medical - UMMC, Northeast Jackson - UMMC, Pavilion - UMMC, University Heart - UMMC, University Hospital - UMMC
January 12, 2022

Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)

Locations: Pavilion - UMMC, University Heart - UMMC, University Hospital - UMMC
January 12, 2022

Prospective comparison of ARNI with ARB Given following stabiLization In DEcompensated HFpEF (PARAGLIDE-HF)

Locations: Emergency Room (Adult) - UMMC, Northeast Jackson - UMMC, Pavilion - UMMC, University Heart - UMMC, University Hospital - UMMC, UMMC LB Building
January 11, 2022

A Randomized, Open-label Study of Dapagliflozin in Patients with Type 2 Diabetes Admitted with Acute Heart Failure

Locations: Emergency Room (Adult) - UMMC, Pavilion - UMMC, University Heart - UMMC
December 16, 2021

Long-Term Safety and Efficacy Outcomes Following Previously Administered Short-Term Treatment with SHP607 in Extremely Premature Infants

Locations: Children’s of Mississippi Hospital - Blair E. Batson Tower
October 26, 2021

Patient attitudes about lung cancer screening at University of Mississippi Medical Center

Locations: University Hospital - UMMC
October 26, 2021

A Phase 3, Randomized, Double-Blind, Placebo Controlled Study of Voxelotor in Pediatric Participants with Sickle Cell Disease and an Open-label Study in Infants with Sickle Cell Disease (HOPE Kids 2)

Locations: Children’s of Mississippi - Batson Kids Clinic
October 26, 2021

A Phase 3, Randomized, Active-Controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Women at High Risk for HIV-1 Infection

Locations: University Hospital - UMMC
October 26, 2021

A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of Oral Islatravir Once-Monthly as Preexposure Prophylaxis in Cisgender Men and Transgender Women Who Have Sex With Men, and Are at High Risk for HIV-1 Infection

Locations: University Hospital - UMMC
October 22, 2021

Long-Term Outcomes after the Multisystem Inflammatory Syndrome in Children: MUSIC

Locations: Children’s of Mississippi Hospital - Blair E. Batson Tower, Eli Manning Children’s Clinics - UMMC, Grants Ferry - UMMC
October 22, 2021

Clinical Evaluation Hemodialysis System for Home Nocturnal Hemodialysis

Locations: University Hospital - UMMC
October 20, 2021

A Multicenter, Randomized, Placebo Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients with Diabetic Cardiomyopathy / Stage B Heart Failure at High Risk of Progression to Overt Heart Failure (Stage C Heart Failure)

Locations: University Heart - UMMC, University Hospital - UMMC
October 20, 2021

A Phase 3b, Multi-center, Randomized, Double-blind, Placebo controlled, Parallel-group Trial with an Open-label Extension Phase to demonstrate that the efficacy of avatrombopag is superior to placebo for the treatment of pediatric subjects with ITP of ≥6 months duration who have had an insufficient response to a previous treatment.

Locations: Cancer Center and Research Institute - UMMC, Children's of Mississippi Hospital - Kathy and Joe Sanderson Tower, Children’s of Mississippi - Batson Kids Clinic, Children’s of Mississippi Hospital - Blair E. Batson Tower
July 01, 2021

Muscular Dystrophy Association (MDA) / Muscular Dystrophy Association Neuromuscular Observational Research (MOVR) Data Hub Protocol

Locations: University Hospital - UMMC